2 – Vaccine Immunology

[1]  P. Lambert,et al.  Unresponsiveness to Lymphoid-Mediated Signals at the Neonatal Follicular Dendritic Cell Precursor Level Contributes to Delayed Germinal Center Induction and Limitations of Neonatal Antibody Responses to T-Dependent Antigens 1 , 2003, The Journal of Immunology.

[2]  B. Pulendran.  Systems vaccinology: Probing humanity’s diverse immune systems with vaccines , 2014, Proceedings of the National Academy of Sciences.

[3]  O. Levy,et al.  Systems vaccinology: a promise for the young and the poor , 2015, Philosophical Transactions of the Royal Society B: Biological Sciences.

[4]  R. Whitley,et al.  Clinical practice. Herpes zoster. , 2002, The New England journal of medicine.

[5]  Ruslan Medzhitov,et al.  Pattern recognition receptors and control of adaptive immunity , 2009, Immunological reviews.

[6]  Derek T O'Hagan,et al.  New generation adjuvants--from empiricism to rational design. , 2015, Vaccine.

[7]  M. Netea,et al.  Trained immunity: consequences for the heterologous effects of BCG vaccination. , 2015, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[8]  M. Kapsenberg.  Dendritic-cell control of pathogen-driven T-cell polarization , 2003, Nature Reviews Immunology.

[9]  D. Gray,et al.  T cell memory is short-lived in the absence of antigen , 1988, Nature.

[10]  P. Ruutu,et al.  Effect of transplacentally acquired tetanus antibodies on the antibody responses to Haemophilus influenzae type b-tetanus toxoid conjugate and tetanus toxoid vaccines in Filipino infants. , 1999, The Pediatric infectious disease journal.

[11]  S. Pierce,et al.  The tipping points in the initiation of B cell signalling: how small changes make big differences , 2010, Nature Reviews Immunology.

[12]  Y. Maldonado,et al.  Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months. , 1998, JAMA.

[13]  D. Longo,et al.  Pneumococcal Vaccination and Revaccination of Older Adults , 2003, Clinical Microbiology Reviews.

[14]  A. Osterhaus,et al.  Measles Immune Suppression: Lessons from the Macaque Model , 2012, PLoS pathogens.

[15]  G. Pravettoni,et al.  Immune response to hepatitis b vaccine given at different injection sites and by different routes a controlled randomized study , 1988, European Journal of Epidemiology.

[16]  D. Grobbee,et al.  Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. , 2015, The New England journal of medicine.

[17]  Clemens,et al.  Accelerated Schedule for Hepatitis B Immunization. , 1995, Journal of travel medicine.

[18]  J. Chies,et al.  Immunodominant viral peptides as determinants of cross-reactivity in the immune system – Can we develop wide spectrum viral vaccines?☆ , 2005, Medical Hypotheses.

[19]  C. Goodnow,et al.  Control systems and decision making for antibody production , 2010, Nature Immunology.

[20]  R. Xavier,et al.  Long-Lasting Effects of BCG Vaccination on Both Heterologous Th1/Th17 Responses and Innate Trained Immunity , 2013, Journal of Innate Immunity.

[21]  D. Goldblatt,et al.  The induction of immunologic memory after vaccination with Haemophilus influenzae type b conjugate and acellular pertussis-containing diphtheria, tetanus, and pertussis vaccine combination. , 1999, The Journal of infectious diseases.

[22]  D. Goldblatt,et al.  Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization. , 1998, The Journal of infectious diseases.

[23]  H. Hsu,et al.  Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan. , 2003, The Journal of infectious diseases.

[24]  C. Combescure,et al.  Environmental and T Cell–Intrinsic Factors Limit the Expansion of Neonatal Follicular T Helper Cells but May Be Circumvented by Specific Adjuvants , 2012, The Journal of Immunology.

[25]  A. Lindberg,et al.  Glycoprotein conjugate vaccines. , 1999, Vaccine.

[26]  U. V. Andrian,et al.  Natural killer cell memory , 2011, Nature Immunology.

[27]  Melody A. Swartz,et al.  Dendritic-cell trafficking to lymph nodes through lymphatic vessels , 2005, Nature Reviews Immunology.

[28]  Michael Keller,et al.  Age-related differences in phenotype and function of CD4+ T cells are due to a phenotypic shift from naive to memory effector CD4+ T cells. , 2005, International immunology.

[29]  A. Zuckerman,et al.  AFFINITY OF ANTIBODY RESPONSES IN MAN TO HEPATITIS B VACCINE DETERMINED WITH SYNTHETIC PEPTIDES , 1984, The Lancet.

[30]  N. Doria-Rose,et al.  Strategies to guide the antibody affinity maturation process. , 2015, Current opinion in virology.

[31]  M. Shlomchik,et al.  Plasticity and Heterogeneity in the Generation of Memory B Cells and Long-Lived Plasma Cells: The Influence of Germinal Center Interactions and Dynamics , 2010, The Journal of Immunology.

[32]  F. Ennis,et al.  Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure. , 1977, The Journal of pediatrics.

[33]  S. Hansen,et al.  Duration of antiviral immunity after smallpox vaccination , 2003, Nature Medicine.

[34]  Alessandro Sette,et al.  Reverse vaccinology: developing vaccines in the era of genomics. , 2010, Immunity.

[35]  C. Siegrist,et al.  Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants. , 2008, The Journal of pediatrics.

[36]  G. Kelsoe,et al.  Immunosenescence and germinal center reaction , 1997, Immunological reviews.

[37]  T. Kündig,et al.  Virus-induced humoral immunity: on how B cell responses are initiated. , 2013, Current opinion in virology.

[38]  S. Abrignani,et al.  Plasticity of Human CD4 T Cell Subsets , 2014, Front. Immunol..

[39]  Y. Cheung,et al.  Hyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trial. , 2010, Vaccine.

[40]  Thomas Gebhardt,et al.  Memory T cell subsets, migration patterns, and tissue residence. , 2013, Annual review of immunology.

[41]  D. Voehringer,et al.  Th2 cells: orchestrating barrier immunity. , 2004, Advances in immunology.

[42]  David Goldblatt,et al.  Immunogenicity of, and Immunologic Memory to, a Reduced Primary Schedule of Meningococcal C-Tetanus Toxoid Conjugate Vaccine in Infants in the United Kingdom , 2003, Infection and Immunity.

[43]  C. Mackay,et al.  Follicular B helper T cells in antibody responses and autoimmunity , 2005, Nature Reviews Immunology.

[44]  M. Zidan,et al.  Age-dependent development of the splenic marginal zone in human infants is associated with different causes of death. , 2004, Human pathology.

[45]  D. Kelly,et al.  Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[46]  H. Whittle,et al.  Hepatitis B immunisation induces higher antibody and memory Th2 responses in new-borns than in adults. , 2004, Vaccine.

[47]  F. Tangy,et al.  HIV-Infected Children Living in Central Africa Have Low Persistence of Antibodies to Vaccines Used in the Expanded Program on Immunization , 2007, PloS one.

[48]  R. Veenhoven,et al.  IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content. , 2009, Vaccine.

[49]  H. Whittle,et al.  Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages , 1995, The Lancet.

[50]  R. Xavier,et al.  BCG-induced trained immunity in NK cells: Role for non-specific protection to infection. , 2014, Clinical immunology.

[51]  Bali Pulendran,et al.  Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity , 2006, The Journal of experimental medicine.

[52]  V. Flamand,et al.  Unbalanced Neonatal CD4+ T-Cell Immunity , 2014, Front. Immunol..

[53]  R. Huebner,et al.  Long-term antibody levels and booster responses in South African children immunized with nonavalent pneumococcal conjugate vaccine. , 2004, Vaccine.

[54]  E. Gardner,et al.  Characterization of antibody responses to annual influenza vaccination over four years in a healthy elderly population. , 2001, Vaccine.

[55]  A. Weintraub.  Immunology of bacterial polysaccharide antigens. , 2003, Carbohydrate research.

[56]  R. Dagan,et al.  A comparison of multiple regimens of pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine and pneumococcal polysaccharide vaccine in toddlers. , 2000, Vaccine.

[57]  C. Whitney,et al.  Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae. , 2008, Vaccine.

[58]  Pawan Kumar,et al.  Th17 cell based vaccines in mucosal immunity. , 2013, Current opinion in immunology.

[59]  Steven Bird,et al.  A Randomized Trial of Alternative Two- and Three-Dose Hepatitis B Vaccination Regimens in Adolescents: Antibody Responses, Safety, and Immunologic Memory , 2001, Pediatrics.

[60]  C. Berek,et al.  Eosinophils are required for the maintenance of plasma cells in the bone marrow , 2011, Nature Immunology.

[61]  T. Kurosaki,et al.  Differentiation and maintenance of long-lived plasma cells. , 2015, Current opinion in immunology.

[62]  C. Siegrist.  Neonatal and early life vaccinology. , 2001, Vaccine.

[63]  Marie-Pierre David,et al.  Long-term persistence of anti-HPV-16 and -18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: modeling of sustained antibody responses. , 2009, Gynecologic oncology.

[64]  John Earl,et al.  Efficacy of high-dose versus standard-dose influenza vaccine in older adults. , 2014, The New England journal of medicine.

[65]  M. Einstein,et al.  Comparison of long-term immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: End-of-study analysis of a Phase III randomized trial , 2014, Human vaccines & immunotherapeutics.

[66]  P. De Wals,et al.  Comparative Long Term Immunogenicity of Two Recombinant Hepatitis B Vaccines and the Effect of a Booster Dose Given After Five Years in a Low Endemicity Country , 2005, The Pediatric infectious disease journal.

[67]  S. Crotty,et al.  Follicular helper CD4 T cells (TFH). , 2011, Annual review of immunology.

[68]  P. Peduzzi,et al.  A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. , 2005, The New England journal of medicine.

[69]  N. Andrews,et al.  Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[70]  K. Toellner,et al.  Recirculating and germinal center B cells differentiate into cells responsive to polysaccharide antigens , 2003, European journal of immunology.

[71]  S. Plotkin.  Complex correlates of protection after vaccination. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[72]  P. Lambert,et al.  Homing and Adhesion Patterns Determine the Cellular Composition of the Bone Marrow Plasma Cell Niche , 2012, The Journal of Immunology.

[73]  P. Goepfert,et al.  Human immunodeficiency virus vaccines. , 2014, Infectious disease clinics of North America.

[74]  M. Netea,et al.  Heterologous Immunological Effects of Early BCG Vaccination in Low-Birth-Weight Infants in Guinea-Bissau: A Randomized-controlled Trial , 2014, The Journal of infectious diseases.

[75]  N. Shastri,et al.  All the peptides that fit: the beginning, the middle, and the end of the MHC class I antigen‐processing pathway , 2005, Immunological reviews.

[76]  K. Agematsu,et al.  Regulation of Aged Humoral Immune Defense against Pneumococcal Bacteria by IgM Memory B Cell , 2005, The Journal of Immunology.

[77]  D. Granoff,et al.  Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine. , 1987, The Journal of pediatrics.

[78]  A. Iwasaki,et al.  Regulation of Adaptive Immunity by the Innate Immune System , 2010, Science.

[79]  R. Noelle,et al.  The immortality of humoral immunity , 2010, Immunological reviews.

[80]  A. Ramsay,et al.  Prime–boost approaches to tuberculosis vaccine development , 2012, Expert review of vaccines.

[81]  R. Rappuoli,et al.  Influenza vaccine immunology , 2011, Immunological reviews.

[82]  Jeff E. Mold,et al.  Maternal Alloantigens Promote the Development of Tolerogenic Fetal Regulatory T Cells in Utero , 2008, Science.

[83]  Jon M Hanifin,et al.  Multiple diagnostic techniques identify previously vaccinated individuals with protective immunity against monkeypox , 2005, Nature Medicine.

[84]  Shinn-Jang Hwang,et al.  Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. , 2015, The New England journal of medicine.

[85]  D. Mant,et al.  Pneumococcal Conjugate and Plain Polysaccharide Vaccines Have Divergent Effects on Antigen-Specific B Cells , 2012, The Journal of infectious diseases.

[86]  J. Poolman,et al.  Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines , 2011, Expert review of vaccines.

[87]  B. Blomberg,et al.  Humoral immune response and B-cell functions including immunoglobulin class switch are downregulated in aged mice and humans. , 2005, Seminars in immunology.

[88]  Daniela Latorre,et al.  Functional heterogeneity of human memory CD4+ T cell clones primed by pathogens or vaccines , 2015, Science.

[89]  I. Jónsdóttir,et al.  Decreased immune response to pneumococcal conjugate vaccine after 23-valent pneumococcal polysaccharide vaccine in children. , 2014, Vaccine.

[90]  C. Siegrist,et al.  Booster vaccination after neonatal priming with acellular pertussis vaccine. , 2010, The Journal of pediatrics.

[91]  Haifeng Song,et al.  Age‐related changes in antibody repertoire: contribution from T cells , 1997, Immunological reviews.

[92]  J. Tew,et al.  Follicular dendritic cells in aging, a “bottle-neck” in the humoral immune response , 2004, Ageing Research Reviews.

[93]  P. Hodgkin,et al.  Decision criteria for resolving isotype switching conflicts by B cells , 2005, European journal of immunology.

[94]  H. Hallander,et al.  Diphtheria antitoxin response to DTP vaccines used in Swedish pertussis vaccine trials, persistence and projection for timing of booster. , 2000, Vaccine.

[95]  T. Kilpi,et al.  Kinetics and Avidity of Antibodies Evoked by Heptavalent Pneumococcal Conjugate Vaccines PncCRM and PncOMPC in the Finnish Otitis Media Vaccine Trial , 2005, Infection and Immunity.

[96]  H. Pabst,et al.  Cell-mediated and antibody immune responses to AIK-C and Connaught monovalent measles vaccine given to 6 month old infants. , 1999, Vaccine.

[97]  Hyun-Dong Chang,et al.  Static and dynamic components synergize to form a stable survival niche for bone marrow plasma cells , 2014, European journal of immunology.

[98]  P. Romero,et al.  Adjuvants that improve the ratio of antigen-specific effector to regulatory T cells enhance tumor immunity. , 2013, Cancer research.

[99]  P. Lambert,et al.  Co-administration of CpG oligonucleotides enhances the late affinity maturation process of human anti-hepatitis B vaccine response. , 2004, Vaccine.

[100]  T. Vesikari,et al.  Oil-in-water emulsion adjuvant with influenza vaccine in young children. , 2011, The New England journal of medicine.

[101]  M. Decker,et al.  Immune Responses in Infants Whose Mothers Received Tdap Vaccine During Pregnancy , 2013, The Pediatric infectious disease journal.

[102]  R. Coffman,et al.  Vaccine adjuvants: putting innate immunity to work. , 2010, Immunity.

[103]  Virginia Pascual,et al.  Induction of ICOS+CXCR3+CXCR5+ TH Cells Correlates with Antibody Responses to Influenza Vaccination , 2013, Science Translational Medicine.

[104]  O. Ramilo,et al.  Challenges in infant immunity: implications for responses to infection and vaccines , 2011, Nature Immunology.

[105]  R. D. Vries,et al.  Measles immune suppression: functional impairment or numbers game? , 2014 .

[106]  S. Plotkin,et al.  Vaccines: correlates of vaccine-induced immunity. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[107]  A. A. Lindberg.  Polyosides (encapsulated bacteria). , 1999, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

[108]  J. Eskola,et al.  Passively acquired anti-tetanus and anti-Haemophilus antibodies and the response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infancy. , 1996, The Pediatric infectious disease journal.

[109]  M. Goldman,et al.  Blood plasmacytoid dendritic cell responses to CpG oligodeoxynucleotides are impaired in human newborns. , 2004, Blood.

[110]  Yuping Deng,et al.  Age-Related Impaired Type 1 T Cell Responses to Influenza: Reduced Activation Ex Vivo, Decreased Expansion in CTL Culture In Vitro, and Blunted Response to Influenza Vaccination In Vivo in the Elderly1 , 2004, The Journal of Immunology.

[111]  W. Timens,et al.  The dual function of the splenic marginal zone: essential for initiation of anti‐TI‐2 responses but also vital in the general first‐line defense against blood‐borne antigens , 2002, Clinical and experimental immunology.

[112]  R. Rappuoli,et al.  Combined Conjugate Vaccines: Enhanced Immunogenicity with the N19 Polyepitope as a Carrier Protein , 2005, Infection and Immunity.

[113]  I. Jónsdóttir,et al.  Hyporesponsiveness following booster immunization with bacterial polysaccharides is caused by apoptosis of memory B cells. , 2012, The Journal of infectious diseases.

[114]  P. Lambert,et al.  Reduced Ability of Neonatal and Early-Life Bone Marrow Stromal Cells to Support Plasmablast Survival1 , 2006, The Journal of Immunology.

[115]  M. Goldman,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Vaccination and Autoimmune Disease: What Is the Evidence? , 2022 .

[116]  S. Self,et al.  Ontogeny of Toll-Like Receptor Mediated Cytokine Responses of Human Blood Mononuclear Cells , 2010, PloS one.

[117]  Robert T. Chen,et al.  Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. , 2004, The New England journal of medicine.

[118]  J. Yewdell,et al.  MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines , 2011, Science Translational Medicine.

[119]  L. Lum,et al.  Decreased specific antibody synthesis in old adults: Decreased potency of antigen-specific B cells with aging , 1990, Mechanisms of Ageing and Development.

[120]  T. Kurosaki,et al.  Memory B cells , 2015, Nature Reviews Immunology.

[121]  K. Toellner,et al.  Extrafollicular antibody responses , 2003, Immunological reviews.

[122]  D. Weiskopf,et al.  Biology of immune responses to vaccines in elderly persons. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[123]  S. Niewiesk,et al.  Insights into the regulatory mechanism controlling the inhibition of vaccine-induced seroconversion by maternal antibodies. , 2011, Blood.

[124]  S. Kjaer,et al.  Dose-Related Differences in Effectiveness of Human Papillomavirus Vaccination Against Genital Warts: A Nationwide Study of 550,000 Young Girls. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[125]  G. Nemerow,et al.  The role of antibody and complement in the control of viral infections. , 1984, The Journal of investigative dermatology.

[126]  K. Lottenbach,et al.  Somatic Hypermutation and Diverse Immunoglobulin Gene Usage in the Human Antibody Response to the Capsular Polysaccharide of Streptococcus pneumoniae Type 6B , 2004, Infection and Immunity.

[127]  D. Farber,et al.  Human memory T cells: generation, compartmentalization and homeostasis , 2013, Nature Reviews Immunology.

[128]  Sujin Lee,et al.  Recent Advances of Vaccine Adjuvants for Infectious Diseases , 2015, Immune network.

[129]  M. D. de Castro,et al.  Nonspecific (Heterologous) Protection of Neonatal BCG Vaccination Against Hospitalization Due to Respiratory Infection and Sepsis. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[130]  D. Lowy,et al.  Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials. , 2015, The Lancet. Oncology.

[131]  Ryan T Novak,et al.  Persistence of Protection Against Hepatitis B Virus Infection Among Adolescents Vaccinated With Recombinant Hepatitis B Vaccine Beginning at Birth: A 15-Year Follow-Up Study , 2008, The Pediatric infectious disease journal.

[132]  H. Robinson,et al.  T cell vaccines for microbial infections , 2005, Nature Medicine.

[133]  N. Andrews,et al.  Avidity maturation following vaccination with a meningococcal recombinant hexavalent PorA OMV vaccine in UK infants. , 2002, Vaccine.

[134]  Antonio Lanzavecchia,et al.  Understanding the generation and function of memory T cell subsets. , 2005, Current opinion in immunology.

[135]  J. Weill,et al.  Human marginal zone B cells. , 2009, Annual review of immunology.

[136]  J. Trape,et al.  Sex-differential and non-specific effects of routine vaccinations in a rural area with low vaccination coverage: an observational study from Senegal. , 2015, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[137]  D. Hafler,et al.  FOXP3+ regulatory T cells in the human immune system , 2010, Nature Reviews Immunology.

[138]  A. Casadevall.  The methodology for determining the efficacy of antibody-mediated immunity. , 2004, Journal of immunological methods.

[139]  Beatrix Grubeck-Loebenstein,et al.  Vaccination in the elderly: an immunological perspective. , 2009, Trends in immunology.

[140]  W. Leonard,et al.  Interleukin-21 Is a Critical Cytokine for the Generation of Virus-Specific Long-Lived Plasma Cells , 2013, Journal of Virology.

[141]  Mark M Davis,et al.  How T cells 'see' antigen , 2005, Nature Immunology.

[142]  D. Lowy,et al.  In vivo mechanisms of vaccine-induced protection against HPV infection. , 2010, Cell host & microbe.

[143]  G. Carcelain,et al.  Distinct Time Effects of Vaccination on Long-Term Proliferative and IFN-γ–producing T Cell Memory to Smallpox in Humans , 2004, The Journal of experimental medicine.

[144]  E. De Gregorio,et al.  MF59 Mediates Its B Cell Adjuvanticity by Promoting T Follicular Helper Cells and Thus Germinal Center Responses in Adult and Early Life , 2015, The Journal of Immunology.

[145]  C. Siegrist,et al.  B-cell responses to vaccination at the extremes of age , 2009, Nature Reviews Immunology.

[146]  O. Levy,et al.  Developmental Biology of the Innate Immune Response: Implications for Neonatal and Infant Vaccine Development , 2009, Pediatric Research.

[147]  H. Whittle,et al.  T cell responses to vaccines in infants: defective IFNγ production after oral polio vaccination , 2002, Clinical and experimental immunology.

[148]  A. Pollard,et al.  Maintaining protection against invasive bacteria with protein–polysaccharide conjugate vaccines , 2009, Nature Reviews Immunology.

[149]  M. Pichichero,et al.  Avidity maturation of antibody to Haemophilus influenzae type b (Hib) after immunization with diphtheria-tetanus-acellular pertussis-hib-hepatitis B combined vaccine in infants. , 1999, The Journal of infectious diseases.

[150]  Nigel Curtis,et al.  Non-specific effect of Bacille Calmette-Guérin vaccine on the immune response to routine immunisations. , 2013, Vaccine.

[151]  Ira Mellman,et al.  Designing vaccines based on biology of human dendritic cell subsets. , 2010, Immunity.

[152]  S. Sakaguchi,et al.  Foxp3+ Treg cells in humoral immunity , 2013, International immunology.

[153]  P. Sly,et al.  Enhancement of vaccine-specific cellular immunity in infants by passively acquired maternal antibody. , 2004, Vaccine.

[154]  A. Rothchild,et al.  In search of a new paradigm for protective immunity to TB , 2014, Nature Reviews Microbiology.

[155]  P. Sly,et al.  Heterogeneity in diphtheria-tetanus-acellular pertussis vaccine-specific cellular immunity during infancy: relationship to variations in the kinetics of postnatal maturation of systemic th1 function. , 2001, The Journal of infectious diseases.

[156]  M. Newport,et al.  Neonatal bacillus Calmette‐Guérin vaccination induces adult‐like IFN‐γ production by CD4+ T lymphocytes , 2001, European journal of immunology.

[157]  T. Merkel,et al.  Bordetella pertussis infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primates , 2012, Mucosal Immunology.

[158]  M. Pichichero.  Challenges in vaccination of neonates, infants and young children. , 2014, Vaccine.

[159]  S. Crotty.  A brief history of T cell help to B cells , 2015, Nature Reviews Immunology.

[160]  E. Zell,et al.  Immunogenicity of high-titre AIK-C or Edmonston-Zagreb vaccines in 3.5-month-old infants, and of medium- or high-titre Edmonston-Zagreb vaccine in 6-month-old infants, in Kinshasa, Zaire. , 1994, Vaccine.

[161]  C. Siegrist.  Blame vaccine interference, not neonatal immunization, for suboptimal responses after neonatal diphtheria, tetanus, and acellular pertussis immunization. , 2008, The Journal of pediatrics.

[162]  T. Merkel,et al.  Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model , 2013, Proceedings of the National Academy of Sciences.

[163]  P. Lambert,et al.  Frequent failure of adolescent booster responses to tetanus toxoid despite infant immunization: waning of infancy-induced immune memory? , 2010, Vaccine.

[164]  M. Pichichero,et al.  Kinetics of booster responses to Haemophilus influenzae type B conjugate after combined diphtheria-tetanus-acelluar pertussis-Haemophilus influenzae type b vaccination in infants. , 1999, The Pediatric infectious disease journal.

[165]  Tony T. Jiang,et al.  Immunosuppressive CD71+ erythroid cells compromise neonatal host defence against infection , 2013, Nature.

[166]  M. Halloran,et al.  Direct and total effectiveness of the intranasal, live-attenuated, trivalent cold-adapted influenza virus vaccine against the 2000-2001 influenza A(H1N1) and B epidemic in healthy children. , 2004, Archives of pediatrics & adolescent medicine.

[167]  R. Wakim,et al.  Effects of interleukin-12 and interleukin-15 on measles-specific T-cell responses in vaccinated infants. , 2008, Viral immunology.

[168]  Umesh Parashar,et al.  Recent resurgence of mumps in the United States. , 2008, The New England journal of medicine.

[169]  A. Kattamis,et al.  Antigen-specific B-cell response to 13-valent pneumococcal conjugate vaccine in asplenic individuals with β-thalassemia previously immunized with 23-valent pneumococcal polysaccharide vaccine. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[170]  G. Glenn,et al.  ISCOMATRIX™ adjuvant promotes epitope spreading and antibody affinity maturation of influenza A H7N9 virus like particle vaccine that correlate with virus neutralization in humans. , 2015, Vaccine.

[171]  M. Roncarolo,et al.  CD4+ regulatory T cells: mechanisms of induction and effector function. , 2005, Autoimmunity reviews.

[172]  T. Kollmann,et al.  Development of immunity in early life. , 2015, The Journal of infection.

[173]  D. Robinson,et al.  Development and function of T helper 1 cells. , 2004, Advances in immunology.

[174]  E. Gilboa,et al.  Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells. , 2005, The Journal of clinical investigation.

[175]  J. McVernon,et al.  Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis , 2003, The Lancet.

[176]  A. Folgori,et al.  Prime-boost vectored malaria vaccines: Progress and prospects , 2010, Human vaccines.

[177]  J. Schenkel,et al.  Tissue-resident memory T cells. , 2014, Immunity.

[178]  W. Bellini,et al.  Enzyme-Linked Immunospot Assay Detection of Mumps-Specific Antibody-Secreting B Cells as an Alternative Method of Laboratory Diagnosis , 2010, Clinical and Vaccine Immunology.

[179]  M. Dietrich,et al.  A new accelerated vaccination schedule for rapid protection against hepatitis A and B. , 2002, Vaccine.

[180]  R. Jacobson,et al.  Application of pharmacogenomics to vaccines. , 2009, Pharmacogenomics.

[181]  C. Siegrist.  Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants. , 2003, Vaccine.

[182]  J. Cyster,et al.  Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position , 2002, Nature.

[183]  J. Neefjes,et al.  MHC class I alleles and their exploration of the antigen‐processing machinery , 2005, Immunological reviews.

[184]  Hao Wu,et al.  Long-Lived Plasma Cells Are Contained within the CD19(-)CD38(hi)CD138(+) Subset in Human Bone Marrow. , 2015, Immunity.

[185]  P. Marrack,et al.  Homeostasis of the Memory T Cell Pool , 2005, International Archives of Allergy and Immunology.

[186]  A. Ortqvist,et al.  Revaccination with the 23-valent pneumococcal polysaccharide vaccine in middle-aged and elderly persons previously treated for pneumonia. , 2003, Vaccine.

[187]  R. Insel.  Potential Alterations in Immunogenicity by Combining or Simultaneously Administering Vaccine Components a , 1995, Annals of the New York Academy of Sciences.

[188]  R. Dagan,et al.  Immunization against hepatitis A in the first year of life: priming despite the presence of maternal antibody. , 2000, The Pediatric infectious disease journal.

[189]  J. Singer,et al.  Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial. , 2013, JAMA.

[190]  C. Jones,et al.  The relationship between concentration of specific antibody at birth and subsequent response to primary immunization. , 2014, Vaccine.

[191]  O. Joffre,et al.  Cross-presentation by dendritic cells , 2012, Nature Reviews Immunology.

[192]  E. Gardner,et al.  Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly , 2002, Experimental Gerontology.

[193]  Glennis A. Logsdon,et al.  Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality , 2015, Science.

[194]  C. Tinelli,et al.  Immunogenicity of a three-component acellular pertussis vaccine administered at birth. , 2003, Pediatrics.

[195]  Peter Aaby,et al.  Differences in female-male mortality after high-titre measles vaccine and association with subsequent vaccination with diphtheria-tetanus-pertussis and inactivated poliovirus: reanalysis of West African studies , 2003, The Lancet.

[196]  E. Shapiro,et al.  Effectiveness over time of varicella vaccine. , 2004, JAMA.

[197]  K. Rajewsky,et al.  Memory B-cell persistence is independent of persisting immunizing antigen , 2000, Nature.

[198]  C. Locht,et al.  Different T cell memory in preadolescents after whole-cell or acellular pertussis vaccination. , 2013, Vaccine.

[199]  T. Ottenhoff,et al.  Regulatory T-Cells at the Interface between Human Host and Pathogens in Infectious Diseases and Vaccination , 2015, Front. Immunol..

[200]  J. Yewdell,et al.  Understanding presentation of viral antigens to CD8+ T cells in vivo: the key to rational vaccine design. , 2005, Annual review of immunology.

[201]  K. Pfeiffer,et al.  Insufficient protection for healthy elderly adults by tetanus and TBE vaccines. , 2005, Vaccine.

[202]  Richard Platt,et al.  Post-PCV7 Changes in Colonizing Pneumococcal Serotypes in 16 Massachusetts Communities, 2001 and 2004 , 2004, Pediatrics.

[203]  F. Stevenson,et al.  Vaccination of human subjects expands both specific and bystander memory T cells but antibody production remains vaccine specific. , 2006, Blood.

[204]  L. Sobin,et al.  Human lymph node morphology as a function of age and site. , 1980, Journal of clinical pathology.

[205]  D. Baxter.  Vaccine responsiveness in premature infants , 2010, Human vaccines.

[206]  Lihan K. Yan,et al.  Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. , 2000, The Journal of infectious diseases.

[207]  Elizabeth Miller,et al.  Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction , 2004, The Lancet.

[208]  D. Granoff,et al.  IMMUNOGENICITY IN INFANTS OF HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE IN A CONJUGATE VACCINE WITH NEISSERIA MENINGITIDIS OUTER-MEMBRANE PROTEIN , 1986, The Lancet.

[209]  C. Katlama,et al.  Cellular CD4 T cell responses to the diphtheria-derived carrier protein of conjugated pneumococcal vaccine and antibody response to pneumococcal vaccination in HIV-infected adults. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[210]  K. O'Brien,et al.  Combined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue? , 2007, The Lancet. Infectious diseases.

[211]  John Steel,et al.  Programming the magnitude and persistence of antibody responses with innate immunity , 2010, Nature.

[212]  H. Marshall,et al.  Acellular Pertussis Vaccine at Birth and One Month Induces Antibody Responses By Two Months of Age , 2010, The Pediatric infectious disease journal.

[213]  P. Offit,et al.  Addressing parents' concerns: do multiple vaccines overwhelm or weaken the infant's immune system? , 2002, Pediatrics.

[214]  S. Bertholet,et al.  Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants , 2014, Proceedings of the National Academy of Sciences.

[215]  N. Simister.  Placental transport of immunoglobulin G. , 2003, Vaccine.

[216]  Imogen Moran,et al.  T follicular helper cells have distinct modes of migration and molecular signatures in naive and memory immune responses. , 2015, Immunity.

[217]  Christophe Fraser,et al.  Modeling the long-term antibody response of a human papillomavirus (HPV) virus-like particle (VLP) type 16 prophylactic vaccine. , 2007, Vaccine.

[218]  A. Mackensen,et al.  Analysis of the immune response against tetanus toxoid: enumeration of specific T helper cells by the Elispot assay. , 2002, Immunobiology.

[219]  Ofer Levy,et al.  Innate immunity of the newborn: basic mechanisms and clinical correlates , 2007, Nature Reviews Immunology.

[220]  R. Rappuoli,et al.  Human circulating influenza-CD4+ ICOS1+IL-21+ T cells expand after vaccination, exert helper function, and predict antibody responses , 2013, Proceedings of the National Academy of Sciences.

[221]  J. Vekemans,et al.  Deficient IL-12(p35) Gene Expression by Dendritic Cells Derived from Neonatal Monocytes1 , 2001, The Journal of Immunology.

[222]  G. Kaplan,et al.  Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guérin vaccination of newborns. , 2010, American journal of respiratory and critical care medicine.

[223]  A. Zanetti,et al.  Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study , 2005, The Lancet.

[224]  S. Salmaso,et al.  Cell-mediated immunity and antibody responses to Bordetella pertussis antigens in children with a history of pertussis infection and in recipients of an acellular pertussis vaccine. , 2000, The Journal of infectious diseases.

[225]  P. Beutels,et al.  Mathematical models for assessment of long‐term persistence of antibodies after vaccination with two inactivated hepatitis A vaccines , 2000, Journal of medical virology.

[226]  M. Linterman.  How T follicular helper cells and the germinal centre response change with age , 2014, Immunology and cell biology.

[227]  Lihan K. Yan,et al.  Induction of human T cell-mediated immune responses after primary and secondary smallpox vaccination. , 2004, The Journal of infectious diseases.

[228]  T. Duke,et al.  Immune response to measles vaccine in 6 month old infants in Papua New Guinea , 2009, Tropical medicine & international health : TM & IH.

[229]  A E Fiore,et al.  Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[230]  S. Niewiesk.  Maternal Antibodies: Clinical Significance, Mechanism of Interference with Immune Responses, and Possible Vaccination Strategies , 2014, Front. Immunol..

[231]  S. Reed,et al.  Use of defined TLR ligands as adjuvants within human vaccines , 2011, Immunological reviews.

[232]  K. Steimer,et al.  Maternal monoclonal antibody to the V3 loop alters specificity of the response to a human immunodeficiency virus vaccine. , 1996, The Journal of infectious diseases.

[233]  A. Lucas,et al.  Polysaccharide vaccines as probes of antibody repertoires in man , 1999, Immunological reviews.

[234]  S. Khader,et al.  Th17 cytokines and vaccine-induced immunity , 2010, Seminars in Immunopathology.

[235]  Peter Aaby,et al.  Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial , 2010, BMJ : British Medical Journal.

[236]  D. Campbell,et al.  Phenotypical and functional specialization of FOXP3+ regulatory T cells , 2011, Nature Reviews Immunology.

[237]  W. Lim,et al.  The long‐term efficacy of plasma‐derived hepatitis B vaccine in babies born to carrier mothers , 2003, Journal of viral hepatitis.

[238]  M. Slifka,et al.  Mechanisms that determine plasma cell lifespan and the duration of humoral immunity , 2010, Immunological reviews.

[239]  J. McVernon,et al.  Immunologic memory in Haemophilus influenzae type b conjugate vaccine failure , 2003, Archives of disease in childhood.

[240]  A. Facchini,et al.  A mathematical model predicting anti‐hepatitis B virus surface antigen (HBs) decay after vaccination against hepatitis B , 1999, Clinical and experimental immunology.

[241]  F. Shann.  Heterologous immunity and the nonspecific effects of vaccines: a major medical advance? , 2004, The Pediatric infectious disease journal.

[242]  P. Hillemanns,et al.  Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared to the licensed 3-dose schedule , 2011, Human vaccines.

[243]  C. Combescure,et al.  Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study. , 2011, Arthritis and rheumatism.

[244]  U. Klein,et al.  Dynamics of B cells in germinal centres , 2015, Nature Reviews Immunology.

[245]  Qing He,et al.  Antibody regulation of T-cell immunity: implications for vaccine strategies against intracellular pathogens , 2004, Expert review of vaccines.

[246]  D. Tarlinton,et al.  Diversity Among Memory B Cells: Origin, Consequences, and Utility , 2013, Science.

[247]  M. Pichichero.  Booster Vaccinations: Can Immunologic Memory Outpace Disease Pathogenesis? , 2009, Pediatrics.

[248]  A. Elliott,et al.  The influence of BCG vaccine strain on mycobacteria-specific and non-specific immune responses in a prospective cohort of infants in Uganda , 2012, Vaccine.

[249]  P. Holt,et al.  Th2-polarisation of cellular immune memory to neonatal pertussis vaccination. , 2010, Vaccine.

[250]  S. Salmaso,et al.  Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience. , 2001, Pediatrics.

[251]  T. Kimman,et al.  Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion. , 2005, The Journal of infectious diseases.

[252]  I. Kang,et al.  Age-Associated Change in the Frequency of Memory CD4+ T Cells Impairs Long Term CD4+ T Cell Responses to Influenza Vaccine1 , 2004, The Journal of Immunology.

[253]  P. Fine.  Non-specific “non-effects” of vaccination , 2004, BMJ : British Medical Journal.

[254]  Nick Andrews,et al.  No evidence of an increase of bacterial and viral infections following Measles, Mumps and Rubella vaccine. , 2009, Vaccine.

[255]  I. Maclennan,et al.  Megakaryocytes constitute a functional component of a plasma cell niche in the bone marrow. , 2010, Blood.

[256]  C. Xueref,et al.  Early appearance of neutralizing antibodies after vaccination with an inactivated hepatitis A vaccine. , 1997, The Journal of infection.

[257]  P. Aaby,et al.  Nonspecific effects of neonatal and infant vaccination: public-health, immunological and conceptual challenges , 2014, Nature Immunology.

[258]  A. Durandy,et al.  Insights into the B cell specific process of immunoglobulin class switch recombination. , 2011, Immunology letters.

[259]  J. McVernon,et al.  Estimating Haemophilus influenzae type b vaccine effectiveness in England and Wales by use of the screening method. , 2003, The Journal of infectious diseases.

[260]  Luis Villarreal,et al.  Cutting Edge: Long-Term B Cell Memory in Humans after Smallpox Vaccination 1 , 2003, The Journal of Immunology.

[261]  Antonio Lanzavecchia,et al.  Maintenance of Serological Memory by Polyclonal Activation of Human Memory B Cells , 2002, Science.

[262]  J. Palefsky,et al.  Human Papillomavirus 16 (HPV 16) and HPV 18 Antibody Responses Measured by Pseudovirus Neutralization and Competitive Luminex Assays in a Two- versus Three-Dose HPV Vaccine Trial , 2010, Clinical and Vaccine Immunology.

[263]  M Burrage,et al.  Responses to a fourth dose of Haemophilus influenzae type B conjugate vaccine in early life , 2004, Archives of Disease in Childhood - Fetal and Neonatal Edition.

[264]  O. Pryds,et al.  Syddansk Universitet Bacillus Calmette-Guérin immunisation at birth and morbidity among Danish children A prospective , randomised , clinical trial , 2015 .

[265]  T. Lieu,et al.  Pertussis in Adolescents and Adults: Should We Vaccinate? , 2005, Pediatrics.

[266]  J. Eskola,et al.  Differences in the avidity of antibodies evoked by four different pneumococcal conjugate vaccines in early childhood. , 1999, Vaccine.

[267]  M. Pichichero.  Protein carriers of conjugate vaccines , 2013, Human vaccines & immunotherapeutics.

[268]  P. Leinikki,et al.  Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland. , 2000, Vaccine.

[269]  I. Jutras,et al.  Phagocytosis: at the crossroads of innate and adaptive immunity. , 2005, Annual review of cell and developmental biology.

[270]  N. Begg,et al.  Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory. , 1999, The Journal of infectious diseases.

[271]  C. Combescure,et al.  Antibody responses to natural influenza A/H1N1/09 disease or following immunization with adjuvanted vaccines, in immunocompetent and immunocompromised children. , 2011, Vaccine.

[272]  J. Poolman,et al.  Glycoconjugate vaccines and immune interference: A review. , 2010, Vaccine.

[273]  N. Sullivan,et al.  Immunology and evolvement of the adenovirus prime, MVA boost Ebola virus vaccine. , 2015, Current opinion in immunology.

[274]  P. Ricciardi-Castagnoli,et al.  The controversial relationship between NLRP3, alum, danger signals and the next‐generation adjuvants , 2010, European journal of immunology.

[275]  M. Weksler,et al.  Changes in the B-cell repertoire with age. , 2000, Vaccine.

[276]  B. LaFleur,et al.  Poor immune responses to a birth dose of diphtheria, tetanus, and acellular pertussis vaccine. , 2008, The Journal of pediatrics.

[277]  M. Linterman,et al.  T follicular helper cells during immunity and tolerance. , 2010, Progress in molecular biology and translational science.

[278]  K. Auranen,et al.  Long-term persistence of immunity after immunisation with Haemophilus influenzae type b conjugate vaccine. , 2003, Vaccine.

[279]  Thomas F. Tedder,et al.  Maintenance of Long-Lived Plasma Cells and Serological Memory Despite Mature and Memory B Cell Depletion during CD20 Immunotherapy in Mice1 , 2008, The Journal of Immunology.

[280]  P. Aaby,et al.  The immunological effects of oral polio vaccine provided with BCG vaccine at birth: a randomised trial. , 2014, Vaccine.

[281]  I. M. Belyakov,et al.  Molecular pathways regulating CD4(+) T cell differentiation, anergy and memory with implications for vaccines. , 2010, Trends in molecular medicine.

[282]  S. Salmaso,et al.  Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis. , 1998, The Journal of pediatrics.